These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30920995)

  • 1. Radiation Monitoring of an Isolation Room for 131I Therapy After the Patients Were Released.
    Karo C; Ideguchi R; Nishi K; Fukuda N; Miura M; Matuda N; Kudo T
    Health Phys; 2019 Oct; 117(4):419-425. PubMed ID: 30920995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-131 contamination from thyroid cancer patients.
    Ibis E; Wilson CR; Collier BD; Akansel G; Isitman AT; Yoss RG
    J Nucl Med; 1992 Dec; 33(12):2110-5. PubMed ID: 1460501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the isolation period of patients with metastatic thyroid cancer treated by 131I according to a new guideline].
    Tsuchimochi S; Nakajo M; Umanodan T; Fukushima N; Shigaki S; Kiku T
    Kaku Igaku; 2001 Nov; 38(6):747-54. PubMed ID: 11806086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
    Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
    Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A portable survey meter method for locating and quantifying removable contamination after 131I therapies.
    Selikson M; Felice M; Forrest R; Lodhi L; McCue J; Reilley J
    Health Phys; 1996 Feb; 70(2):245-9. PubMed ID: 8567293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
    Grigsby PW; Siegel BA; Baker S; Eichling JO
    JAMA; 2000 May; 283(17):2272-4. PubMed ID: 10807387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioactive iodine (I-131) therapy isolation rooms: Introduction of lead glass window on the wall for patient comfort and better ambience.
    Al Aamri M; Ravichandran R; Al Balushi N
    World J Nucl Med; 2019; 18(1):42-44. PubMed ID: 30774545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RADIATION PROTECTION IN THE RELEASE OF PATIENTS RECEIVING 131I TREATMENT.
    Mattar E; Salih MA; Alsafi K; Suliman II
    Radiat Prot Dosimetry; 2019 Dec; 187(4):499-508. PubMed ID: 31605121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some experiences with treating thyroid cancer patients.
    Achey B; Miller KL; Erdman M; King S
    Health Phys; 2001 May; 80(5 Suppl):S62-6. PubMed ID: 11316085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing prediction capabilities of an 131I terrestrial transport model by using measurements collected at the Hanford nuclear facility.
    Apostoaei AI
    Health Phys; 2005 May; 88(5):439-58. PubMed ID: 15824593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.
    Chu BP; Horan C; Basu E; Dauer L; Williamson M; Carrasquillo JA; Pandit-Taskar N; Modak S
    Pediatr Blood Cancer; 2016 May; 63(5):801-7. PubMed ID: 26773712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of 131I excretions and used materials of patients treated with 131I along with the air contamination level].
    Nishizawa K; Ohara K; Oshima M; Maekoshi H; Orito T; Watanabe T
    Kaku Igaku; 1980 Jul; 17(6):691-7. PubMed ID: 7206348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
    Siekierzyński M
    Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of 131I in perspiration of thyroid carcinoma patients administered 131I for therapy (author's transl)].
    Ohara K; Nisizawa K; Oshima M; Maekoshi H; Orito T; Watanabe T
    Kaku Igaku; 1978 Oct; 15(7):1049-53. PubMed ID: 739676
    [No Abstract]   [Full Text] [Related]  

  • 17. An engagement factor for caregiver radiation dose assessment with radioiodine treatment.
    Lee HK; Hong SJ; Jeong KH; Jung JW; Kim SM; Kang YH; Han MS
    Radiat Prot Dosimetry; 2015 Mar; 163(4):499-508. PubMed ID: 25028695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I.
    Siegel JA; Marcus CS; Stabin MG
    Health Phys; 2007 Dec; 93(6):667-77. PubMed ID: 17993847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation exposure to comforters and carers during paediatric molecular radiotherapy.
    Gains JE; Walker C; Sullivan TM; Waddington WA; Fersht NL; Sullivan KP; Armstrong E; D'Souza DP; Aldridge MD; Bomanji JB; Gaze MN
    Pediatr Blood Cancer; 2015 Feb; 62(2):235-239. PubMed ID: 25284346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.